Breast Lobular Carcinoma — Trials

Breast Lobular Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

81 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 26
Recruiting: 15
Ph III recruiting: 0
Growth YoY: —
Industry share: 8%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (10)

clinicaltrialsPublishedShowing 1–10 of 10 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03317405	Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery	active not recruiting	Phase 1	32	National Cancer Institute (NCI)NIH	1	Sep 2, 2026	clinicaltrials
NCT06557148	A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer	active not recruiting	—	7	Memorial Sloan Kettering Cancer CenterOTHER	1	Jul 14, 2026	clinicaltrials